Navigation Links
Cardiovascular Diseases in India To be Studied Jointly By John Hopkins And Apollo Hospitals

Johns Hopkins Medicine International from the US and Apollo hospitals will undertake a combined study on the genetic reasons of cardiovascular disease in Indians.//

It was explained that in July last year, Apollo Hospitals had come into an agreement with Johns Hopkins to work jointly in areas like telemedicine, second opinion services, continuing medical education programmes, and participation in clinical trials.

Susan J. Zieman, assistant professor, medicines of John Hopkins on Tuesday in N.Delhi said, “The collaborative study will document the risk factors and identify genes that are associated with the premature CVD among Indians.” She further explained that the study is primarily being undertaken at the 3 Apollo hospitals, in Delhi, Hyderabad, and Chennai, to identify the risk factors in Asian Indians who have experienced myocardial infraction at a young age.

She further mentioning that “It will also investigate potential genetic variants associated with early onset of myocardial infraction, elevated risk factors and sub clinical CVD,” she said that the study will take samples from patients, their siblings and general people. Sunil Modi, a senior consultant and interventional cardiologist of the Apollo hospitals, while speaking to the media said, “Indians are 3.8 times more prone to the disease than residents of Singapore, three times more than Fijians, 2.4 times more than people of Trinidad, 1.4 times higher than South Africans and 1.5 times higher than British.”

Stating that almost around 8% of Indian population are probably suffering from heart diseases, Dr Modi said, “The study will take a sample of 1,500 people and conduct over 400 tests before reaching any conclusion. While the base of the study will be India, John Hopkins will provide us the some of the know how and research methodology. Of the over 400 tests some of the tests will also be conducted in the US. The clinical trails credibility of Johns Hopkins will definitely make our effort more meaningful.”

S.K. Aggarwal, a senior consultant in internal medicine said that the study would also look into the effect of administering ‘Polypill’ for reduction of CVD in patients. It was explained that Polypill is actually a mixture of three scheduled drugs, namely Aspirin, Statin, and ECE Inhibitor. It was explained that these three drugs are known for their action in reducing blood clot, cholesterol, and blood pressure.

Zieman said, “The polypill can be an effective medicine to reduce CVD but for that we will study the effect of the drug in its entirety. If successful the medicine can be used as a cost effective way to control the coronary heart diseases”


'"/>




Related medicine news :

1. High iron levels may cause Cardiovascular Disease in women
2. Air Pollution said To Increase Risk of Cardiovascular Disease
3. Link Between Alcohol Consumption And Cardiovascular Disease
4. Beer Found To Be Effective In Fighting Cardiovascular Disease
5. New Guidelines Found To Benefit Cardiovascular Treatment
6. Women With A High-Risk Of Cardiovascular Disease Under treated
7. Obesity and Physical inactivity is associated with Diabetes and Diabetes-Related Cardiovascular Comorbidities
8. Fitness levels in Men Correale with risk of Cardiovascular disease
9. Obesity Common Thread In Pregnancy Complications And Cardiovascular Woes
10. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
11. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology: